Oncopeptides AB (publ) (FRA:OND)

Oncopeptides AB Revenue

Oncopeptides AB had revenue of 20.21M SEK in the quarter ending September 30, 2025, with 137.62% growth. This brings the company's revenue in the last twelve months to 62.47M, up 130.75% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.

• Revenue (ttm): 62.47M SEK
• Revenue Growth: +130.75%
• P/S Ratio: 13.47
• Revenue / Employee: 832.87K SEK
• Employees: 75
• Market Cap: 76.10M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.65M	-3.57M	-10.14%
Dec 31, 2023	35.22M	26.87M	321.54%
Dec 31, 2022	8.36M	-109.94M	-92.94%
Dec 31, 2021	118.30M	-	-
Dec 31, 2020	-	-	-